Patent details

EP2998405 Title: ANTI-HUMAN CD52 IMMUNOGLOBULINS

Basic Information

Publication number:
EP2998405
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP151913514
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-HUMAN CD52 IMMUNOGLOBULINS
French Title of Invention:
IMMUNOGLOBULINES ANTI CD52 HUMAIN
German Title of Invention:
ANTI-HUMAN-CD52-IMMUNGLOBULINE
SPC Number:

Dates

Filing date:
13/05/2010
Grant date:
11/12/2019
EP Publication Date:
23/03/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/12/2019
EP B1 Publication Date:
11/12/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/05/2020
Expiration date:
13/05/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/12/2019
 
 

Name:
Genzyme Corporation
Address:
50 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
SIDERS, William M.
Address:
United States (US)

2

Name:
ROBERTS, Bruce L.
Address:
United States (US)

3

Name:
BRONDYK, William Harold
Address:
United States (US)

4

Name:
SHANKARA, Srinivas
Address:
United States (US)

Priority

Priority Number:
177837 P
Priority Date:
13/05/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61K 39/395; C07K 16/28; C12P 21/08;

Publication

European Patent Bulletin

1

Issue number:
201950
Publication date:
11/12/2019
Description:
Grant (B1)

2

Issue number:
202003
Publication date:
15/01/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages